124 related articles for article (PubMed ID: 35988268)
21. Aberrant expression of miR-196a in gastric cancers and correlation with recurrence.
Tsai KW; Liao YL; Wu CW; Hu LY; Li SC; Chan WC; Ho MR; Lai CH; Kao HW; Fang WL; Huang KH; Lin WC
Genes Chromosomes Cancer; 2012 Apr; 51(4):394-401. PubMed ID: 22420029
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the Diagnostic Properties of Serum hsa-miR-223-5p in the Detection of Gastric Cancer: A Case-Control Study.
Aalami AH; Pouresmaeil V; Amirabadi A; Mojahed FH; Rad MQ; Sahebkar A
Anticancer Agents Med Chem; 2020; 20(7):800-808. PubMed ID: 32013852
[TBL] [Abstract][Full Text] [Related]
23. Increased Expression of MicroRNA-221 in gastric cancer and its clinical significance.
Liu K; Li G; Fan C; Diao Y; Wu B; Li J
J Int Med Res; 2012; 40(2):467-74. PubMed ID: 22613407
[TBL] [Abstract][Full Text] [Related]
24. Gastric juice microRNA-421 is a new biomarker for screening gastric cancer.
Zhang X; Cui L; Ye G; Zheng T; Song H; Xia T; Yu X; Xiao B; Le Y; Guo J
Tumour Biol; 2012 Dec; 33(6):2349-55. PubMed ID: 22926798
[TBL] [Abstract][Full Text] [Related]
25. MiR-638 regulates gastric cardia adenocarcinoma cell proliferation, apoptosis, migration and invasion by targeting MACC1.
Wei CJ; Zhang ZW; Lu JH; Mao YM
Neoplasma; 2020 May; 67(3):537-546. PubMed ID: 32064885
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers.
Liu HT; Xing AY; Chen X; Ma RR; Wang YW; Shi DB; Zhang H; Li P; Chen HF; Li YH; Gao P
Oncotarget; 2015 Nov; 6(35):37458-70. PubMed ID: 26460960
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-335-5p is a potential suppressor of metastasis and invasion in gastric cancer.
Sandoval-Bórquez A; Polakovicova I; Carrasco-Véliz N; Lobos-González L; Riquelme I; Carrasco-Avino G; Bizama C; Norero E; Owen GI; Roa JC; Corvalán AH
Clin Epigenetics; 2017; 9():114. PubMed ID: 29075357
[TBL] [Abstract][Full Text] [Related]
28. Expression Analysis of mir-21 and mir-221 in Cancerous Tissues from Iranian Patients with Gastric Cancer.
Effatpanah H; Yadegarazari R; Karami M; Majlesi A; Shabab N; Saidijam M
Iran Biomed J; 2015; 19(4):188-93. PubMed ID: 26209976
[TBL] [Abstract][Full Text] [Related]
29. [Deregulation of microRNAs in gastric cancer: up regulation by miR-21 and miR-106].
Arias Sosa LA; Cuspoca Orduz AF; Bernal Gómez BM
Rev Gastroenterol Peru; 2017; 37(1):65-70. PubMed ID: 28489839
[TBL] [Abstract][Full Text] [Related]
30. miR-488 acts as a tumor suppressor gene in gastric cancer.
Zhao Y; Lu G; Ke X; Lu X; Wang X; Li H; Ren M; He S
Tumour Biol; 2016 Jul; 37(7):8691-8. PubMed ID: 26738864
[TBL] [Abstract][Full Text] [Related]
31. The expression profiling of circulating miR-204, miR-182, and lncRNA H19 as novel potential biomarkers for the progression of peptic ulcer to gastric cancer.
Mohamed WA; Schaalan MF; Ramadan B
J Cell Biochem; 2019 Aug; 120(8):13464-13477. PubMed ID: 30945348
[TBL] [Abstract][Full Text] [Related]
32. Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma.
Chen Z; Saad R; Jia P; Peng D; Zhu S; Washington MK; Zhao Z; Xu Z; El-Rifai W
Cancer; 2013 Jun; 119(11):1985-93. PubMed ID: 23456798
[TBL] [Abstract][Full Text] [Related]
33. Expression levels of microRNA-192 and -215 in gastric carcinoma.
Chiang Y; Zhou X; Wang Z; Song Y; Liu Z; Zhao F; Zhu J; Xu H
Pathol Oncol Res; 2012 Jul; 18(3):585-91. PubMed ID: 22205577
[TBL] [Abstract][Full Text] [Related]
34. Relationship between miR-378c and YY1 expression in patients with gastric cancer and the clinicopathological features.
Zhang L; Zou L; Sun P
Cell Mol Biol Lett; 2021 Apr; 26(1):12. PubMed ID: 33794762
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer.
He C; Wang L; Zhang J; Xu H
Mol Cancer; 2017 Feb; 16(1):35. PubMed ID: 28173803
[TBL] [Abstract][Full Text] [Related]
36. Plasma miR-940 may serve as a novel biomarker for gastric cancer.
Liu X; Kwong A; Sihoe A; Chu KM
Tumour Biol; 2016 Mar; 37(3):3589-97. PubMed ID: 26456959
[TBL] [Abstract][Full Text] [Related]
37. miRNAs as potential biomarkers for the progression of gastric cancer inhibit CREBZF and regulate migration of gastric adenocarcinoma cells.
Kim YJ; Jeong S; Jung WY; Choi JW; Hwang KC; Kim SW; Lee YC
Int J Med Sci; 2020; 17(6):693-701. PubMed ID: 32218690
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA hsa-mir-3923 serves as a diagnostic and prognostic biomarker for gastric carcinoma.
Yang X; Zhang Z; Zhang L; Zhou L
Sci Rep; 2020 Mar; 10(1):4672. PubMed ID: 32170105
[TBL] [Abstract][Full Text] [Related]
39. The Rs4938723 Polymorphism Reduces Expression of MicroRNA-34b and Increases the Risk of Recurrence after Endoscopic Dissection in Early Gastric Cancer.
Yu K
Cell Physiol Biochem; 2017; 43(3):1235-1246. PubMed ID: 28977792
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of circulating miR-21 and miR-222 as diagnostic biomarkers for gastric cancer.
Emami SS; Nekouian R; Akbari A; Faraji A; Abbasi V; Agah S
J Cancer Res Ther; 2019; 15(1):115-119. PubMed ID: 30880765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
